154 related articles for article (PubMed ID: 12669246)
41. Evaluation of B7-1 (CD80) and B7-2 (CD86) costimulatory molecules and dendritic cells on the immune response in leprosy.
Santos DO; Santos SL; Esquenazi D; Nery JA; Defruyt M; Lorré K; Van Heuverswyn H
Nihon Hansenbyo Gakkai Zasshi; 2001 Feb; 70(1):15-24. PubMed ID: 11244783
[TBL] [Abstract][Full Text] [Related]
42. Mitogenic stimulation of T cells reveals differing contributions for B7-1 (CD80) and B7-2 (CD86) costimulation.
Perrin PJ; Davis TA; Smoot DS; Abe R; June CH; Lee KP
Immunology; 1997 Apr; 90(4):534-42. PubMed ID: 9176106
[TBL] [Abstract][Full Text] [Related]
43. Serum-free generation and quantification of functionally active Leukemia-derived DC is possible from malignant blasts in acute myeloid leukemia and myelodysplastic syndromes.
Kufner S; Fleischer RP; Kroell T; Schmid C; Zitzelsberger H; Salih H; de Valle F; Treder W; Schmetzer HM
Cancer Immunol Immunother; 2005 Oct; 54(10):953-70. PubMed ID: 15789235
[TBL] [Abstract][Full Text] [Related]
44. Human T cell activation by costimulatory signal-deficient allogeneic cells induces inducible costimulator-expressing anergic T cells with regulatory cell activity.
Vermeiren J; Ceuppens JL; Van Ghelue M; Witters P; Bullens D; Mages HW; Kroczek RA; Van Gool SW
J Immunol; 2004 May; 172(9):5371-8. PubMed ID: 15100277
[TBL] [Abstract][Full Text] [Related]
45. B7 costimulatory ligand regulates development of the T-cell response to Cryptococcus neoformans.
Monari C; Kozel TR; Casadevall A; Pietrella D; Palazzetti B; Vecchiarelli A
Immunology; 1999 Sep; 98(1):27-35. PubMed ID: 10469230
[TBL] [Abstract][Full Text] [Related]
46. Activation of human dendritic cells by porcine aortic endothelial cells: transactivation of naïve T cells through costimulation and cytokine generation.
Manna PP; Duffy B; Olack B; Lowell J; Mohanakumar T
Transplantation; 2001 Nov; 72(9):1563-71. PubMed ID: 11707746
[TBL] [Abstract][Full Text] [Related]
47. Differential expression of B7 co-stimulatory molecules by astrocytes correlates with T cell activation and cytokine production.
Soos JM; Ashley TA; Morrow J; Patarroyo JC; Szente BE; Zamvil SS
Int Immunol; 1999 Jul; 11(7):1169-79. PubMed ID: 10383950
[TBL] [Abstract][Full Text] [Related]
48. Costimulatory effects of T cell proliferation during infection with human T lymphotropic virus types I and II are mediated through CD80 and CD86 ligands.
Lal RB; Rudolph DL; Dezzutti CS; Linsley PS; Prince HE
J Immunol; 1996 Aug; 157(3):1288-96. PubMed ID: 8757637
[TBL] [Abstract][Full Text] [Related]
49. Cytokine responsiveness of mitogen-activated T cells derived from acute leukemia patients with chemotherapy-induced leukopenia.
Bruserud O; Ulvestad E
J Interferon Cytokine Res; 2000 Nov; 20(11):947-54. PubMed ID: 11096451
[TBL] [Abstract][Full Text] [Related]
50. Functional expression of costimulatory molecule CD86 on epithelial cells in the inflamed colonic mucosa.
Nakazawa A; Watanabe M; Kanai T; Yajima T; Yamazaki M; Ogata H; Ishii H; Azuma M; Hibi T
Gastroenterology; 1999 Sep; 117(3):536-45. PubMed ID: 10464129
[TBL] [Abstract][Full Text] [Related]
51. T-cell alterations in cardiac allograft recipients after B7 (CD80 and CD86) blockade.
Woodward JE; Bayer AL; Chavin KD; Blue ML; Baliga P
Transplantation; 1998 Jul; 66(1):14-20. PubMed ID: 9679816
[TBL] [Abstract][Full Text] [Related]
52. Costimulatory molecules in human atherosclerotic plaques: an indication of antigen specific T lymphocyte activation.
de Boer OJ; Hirsch F; van der Wal AC; van der Loos CM; Das PK; Becker AE
Atherosclerosis; 1997 Sep; 133(2):227-34. PubMed ID: 9298683
[TBL] [Abstract][Full Text] [Related]
53. CD80, CD86 and CD40 provide accessory signals in a multiple-step T-cell activation model.
Van Gool SW; Vandenberghe P; de Boer M; Ceuppens JL
Immunol Rev; 1996 Oct; 153():47-83. PubMed ID: 9010719
[TBL] [Abstract][Full Text] [Related]
54. Human resting B lymphocytes can serve as accessory cells for anti-CD2-induced T cell activation.
Hirokawa M; Gray JD; Takahashi T; Horwitz DA
J Immunol; 1992 Sep; 149(6):1859-66. PubMed ID: 1355500
[TBL] [Abstract][Full Text] [Related]
55. The capacity of the natural ligands for CD28 to drive IL-4 expression in naïve and antigen-primed CD4+ and CD8+ T cells.
Bian Y; Hiraoka S; Tomura M; Zhou XY; Yashiro-Ohtani Y; Mori Y; Shimizu J; Ono S; Dunussi-Joannopoulos K; Wolf S; Fujiwara H
Int Immunol; 2005 Jan; 17(1):73-83. PubMed ID: 15569772
[TBL] [Abstract][Full Text] [Related]
56. IL-10 down-regulates costimulatory molecules on Mycobacterium tuberculosis-pulsed macrophages and impairs the lytic activity of CD4 and CD8 CTL in tuberculosis patients.
de la Barrera S; Aleman M; Musella R; Schierloh P; Pasquinelli V; Garcia V; Abbate E; Sasiain Mdel C
Clin Exp Immunol; 2004 Oct; 138(1):128-38. PubMed ID: 15373915
[TBL] [Abstract][Full Text] [Related]
57. Reduced alloreactive T-cell activation after alcohol intake is due to impaired monocyte accessory cell function and correlates with elevated IL-10, IL-13, and decreased IFNgamma levels.
Szabo G; Mandrekar P; Dolganiuc A; Catalano D; Kodys K
Alcohol Clin Exp Res; 2001 Dec; 25(12):1766-72. PubMed ID: 11781510
[TBL] [Abstract][Full Text] [Related]
58. Expression of co-stimulatory molecules on acute myeloid leukaemia blasts may effect duration of first remission.
Whiteway A; Corbett T; Anderson R; Macdonald I; Prentice HG
Br J Haematol; 2003 Feb; 120(3):442-51. PubMed ID: 12580958
[TBL] [Abstract][Full Text] [Related]
59. FcR cross-linking on monocytes results in impaired T cell stimulatory capacity.
Barcy S; Wettendorff M; Leo O; Urbain J; Kruger M; Ceuppens JL; de Boer M
Int Immunol; 1995 Feb; 7(2):179-89. PubMed ID: 7537534
[TBL] [Abstract][Full Text] [Related]
60. Ex vivo generation of human anti-pre-B leukemia-specific autologous cytolytic T cells.
Cardoso AA; Seamon MJ; Afonso HM; Ghia P; Boussiotis VA; Freeman GJ; Gribben JG; Sallan SE; Nadler LM
Blood; 1997 Jul; 90(2):549-61. PubMed ID: 9226154
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
